Wellumio

Wellumio

Private
WellingtonHealthcare & Life Scienceshttps://wellumio.com

Last Round

Pre Seed

Nov 2, 2025

Est. Valuation

$14.15M

Total Funding Raised

$4.79M

Company Overview

Wellumio is a diagnostic equipment company that has developed Axana, a portable magnetic resonance-based imaging device intended for the rapid diagnosis of acute stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

portable MRIpoint-of-care MRIstroke diagnosisbedside MRIneuroimagingmedical devicestroke triagemedical imagingpoint-of-care diagnosismobile MRIPulsed Gradient-Free MappingPGFMcontrast-free perfusion imagingpre-hospital diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wellumio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Wellumio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedNov 2, 2025
SeedAug 24, 2023

Key People

Founding team and executive leadership

Sergei Obruchkov

Co-Founder And Co-CEO, CTO

Founding Team

Shieak Tzeng

Co-Founder CEO

Founding Team

Wellumio Investors

Notable investors and investment history

InvestorRounds
Icehouse VenturesSeed, Pre Seed
Outset VenturesPre Seed, Seed
Bridgewest Venture FundPre Seed
New Zealand Growth Capital PartnersSeed
Cure Kids VenturesSeed, Pre Seed
Booster Innovation FundSeed, Pre Seed
MovacSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 28, 2026

    Developing a new product named 'Axana', currently in design and testing phases.

  • Apr 10, 2025

    Partnering with Nicolab to integrate Axana MRI with StrokeViewer platform.

Wellumio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wellumio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wellumio's valuation, stock price, and market status.

Firmographic Details

HeadquartersWellington
Employee Range12
Year Founded2019
Last FundingNov 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.